UK Myeloma Research Alliance-Myeloma UK–Concept and Access Research Programme
The UKMRA-Myeloma UK-CARP is an evolution of the Myeloma UK Clinical Trials Network.
This is the only initiative in the UK focused on the development of early phase trials to meet the needs of myeloma patients. The initiative focuses on designing trials and answering the questions which matter most to UK myeloma patients, carers and myeloma specialists. It also aims to put UK at the forefront myeloma research, so that patients here can get early access to experimental treatments.
This collaborative model combines the funding and patient insight from Myeloma UK, with the experience and expertise of the UK Myeloma Research Alliance and the University of Leeds Clinical Trials Research Unit. These trials will either provide a proof of concept data for larger and later phase trials, or data which can be used to support patients gaining access to treatments through the NHS.
The initiative will explore innovative trials designs such as ‘adaptive trials’, which allows researchers to learn from patient responses to treatment during the trial and gives them flexibility to adapt the treatment accordingly.
The UKMRA-Myeloma UK-CARP will help improve myeloma treatments, innovate myeloma research and give UK myeloma patients access to new treatments or treatment combinations as part of trials.